Follow
Alan I. So
Alan I. So
Associate Professor, Urologic Sciences, University of British Columbia
No verified email
Title
Cited by
Cited by
Year
Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer
P Rocchi, A So, S Kojima, M Signaevsky, E Beraldi, L Fazli, ...
Cancer research 64 (18), 6595-6602, 2004
3912004
Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance
C Kollmannsberger, T Tandstad, PL Bedard, G Cohn-Cedermark, ...
J Clin Oncol 33 (1), 51-7, 2015
3292015
Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell …
IP Trougakos, A So, B Jansen, ME Gleave, ES Gonos
Cancer research 64 (5), 1834-1842, 2004
2952004
Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells
M Kamada, A So, M Muramaki, P Rocchi, E Beraldi, M Gleave
Molecular cancer therapeutics 6 (1), 299-308, 2007
2272007
Mechanisms of the development of androgen independence in prostate cancer
A So, M Gleave, A Hurtado-Col, C Nelson
World journal of urology 23, 1-9, 2005
2152005
Treatment outcomes and tumor loss of heterozygosity in germline DNA repair–deficient prostate cancer
M Annala, WJ Struss, EW Warner, K Beja, G Vandekerkhove, A Wong, ...
European urology 72 (1), 34-42, 2017
2142017
Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo
LV July, E Beraldi, A So, L Fazli, K Evans, JC English, ME Gleave
Molecular cancer therapeutics 3 (3), 223-232, 2004
1972004
Small interference RNA targeting heat‐shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase‐3 activation in vitro
P Rocchi, P Jugpal, A So, S Sinneman, S Ettinger, L Fazli, C Nelson, ...
BJU international 98 (5), 1082-1089, 2006
1722006
Circulating tumor DNA abundance and potential utility in de novo metastatic prostate cancer
G Vandekerkhove, WJ Struss, M Annala, HML Kallio, D Khalaf, ...
European urology 75 (4), 667-675, 2019
1712019
Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E
C Andrieu, D Taieb, V Baylot, S Ettinger, P Soubeyran, A De-Thonel, ...
Oncogene 29 (13), 1883-1896, 2010
1682010
Outcomes of active surveillance for clinically localized prostate cancer in the prospective, multi-institutional Canary PASS cohort
LF Newcomb, IM Thompson, HD Boyer, JD Brooks, PR Carroll, ...
The Journal of urology 195 (2), 313-320, 2016
1642016
Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery
C Kollmannsberger, S Daneshmand, A So, KN Chi, N Murray, C Moore, ...
Journal of clinical oncology 28 (4), 537-542, 2010
1522010
Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer
BJ Davison, AI So, SL Goldenberg
BJU international 100 (4), 780-785, 2007
1502007
Clusterin knockdown using the antisense oligonucleotide OGX‐011 re‐sensitizes docetaxel‐refractory prostate cancer PC‐3 cells to chemotherapy
RD Sowery, BA Hadaschik, AI So, A Zoubeidi, L Fazli, A Hurtado‐Coll, ...
BJU international 102 (3), 389-397, 2008
1452008
Active surveillance is the preferred approach to clinical stage I testicular cancer
CR Nichols, B Roth, P Albers, LH Einhorn, R Foster, S Daneshmand, ...
Journal of Clinical Oncology 31 (28), 3490-3493, 2013
1432013
The 2015 CUA-CUOG Guidelines for the management of castration-resistant prostate cancer (CRPC)
F Saad, KN Chi, A Finelli, SJ Hotte, J Izawa, A Kapoor, W Kassouf, ...
Canadian Urological Association Journal 9 (3-4), 90, 2015
1352015
Effect of nitroxoline on angiogenesis and growth of human bladder cancer
JS Shim, Y Matsui, S Bhat, BA Nacev, J Xu, HC Bhang, S Dhara, KC Han, ...
Journal of the National Cancer Institute 102 (24), 1855-1873, 2010
1232010
ASAP1, a gene at 8q24, is associated with prostate cancer metastasis
D Lin, A Watahiki, J Bayani, F Zhang, L Liu, V Ling, MD Sadar, J English, ...
Cancer research 68 (11), 4352-4359, 2008
1222008
Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo
A So, S Sinnemann, D Huntsman, L Fazli, M Gleave
Molecular cancer therapeutics 4 (12), 1837-1849, 2005
1212005
Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy
C Mugabe, BA Hadaschik, RK Kainthan, DE Brooks, AI So, ME Gleave, ...
Bju International 103 (7), 978-986, 2009
1102009
The system can't perform the operation now. Try again later.
Articles 1–20